drugset / Trial / NCT00839631
Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors
Timeline
- Start
- 2009-03
- Primary completion
- 2011-12
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D-3263 | Unknown | 50 mg | Oral |